155 related articles for article (PubMed ID: 32103731)
1. Prevalence, associated factors and medication for symptoms related to gastroesophageal reflux disease among 1114 private-tuition students of Anuradhapura, Sri Lanka.
Gunasinghe D; Gunawardhana C; Halahakoon S; Haneeka A; Hanim N; Hapuarachchi C; Rathish D
BMC Gastroenterol; 2020 Feb; 20(1):45. PubMed ID: 32103731
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of gastro-oesophageal reflux disease symptoms and reflux-associated respiratory symptoms in asthma.
Amarasiri LD; Pathmeswaran A; de Silva HJ; Ranasinha CD
BMC Pulm Med; 2010 Sep; 10():49. PubMed ID: 20843346
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational study.
Martigne L; Delaage PH; Thomas-Delecourt F; Bonnelye G; Barthélémy P; Gottrand F
Eur J Pediatr; 2012 Dec; 171(12):1767-73. PubMed ID: 22903328
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care.
Ruigómez A; García Rodríguez LA; Wallander MA; Johansson S; Dent J
Curr Med Res Opin; 2006 Sep; 22(9):1661-8. PubMed ID: 16968569
[TBL] [Abstract][Full Text] [Related]
5. The association between symptoms of gastroesophageal reflux disease and perceived stress: A countrywide study of Sri Lanka.
Wickramasinghe N; Thuraisingham A; Jayalath A; Wickramasinghe D; Samarasekara N; Yazaki E; Devanarayana NM
PLoS One; 2023; 18(11):e0294135. PubMed ID: 37943748
[TBL] [Abstract][Full Text] [Related]
6. Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.
Jones R; Horbach S; Sander P; Rydén-Bergsten T
Pharmacoeconomics; 2003; 21(15):1091-102. PubMed ID: 14596628
[TBL] [Abstract][Full Text] [Related]
7. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.
Rosaida MS; Goh KL
Eur J Gastroenterol Hepatol; 2004 May; 16(5):495-501. PubMed ID: 15097043
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, associated factors and reasons for antibiotic self-medication among dwellers in Anuradhapura: a community-based study.
Rathish D; Wickramasinghe ND
Int J Clin Pharm; 2020 Aug; 42(4):1139-1144. PubMed ID: 32458226
[TBL] [Abstract][Full Text] [Related]
9. Pharyngeal and laryngeal symptoms and signs related to extraesophageal reflux in patients with heartburn in gastroenterology practice: a prospective study.
Ylitalo R; Lindestad P; Hertegård S
Clin Otolaryngol; 2005 Aug; 30(4):347-52. PubMed ID: 16209677
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community.
Watson DI; Lally CJ
World J Surg; 2009 Jan; 33(1):88-94. PubMed ID: 18949510
[TBL] [Abstract][Full Text] [Related]
11. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers.
El-Serag HB; Satia JA; Rabeneck L
Gut; 2005 Jan; 54(1):11-7. PubMed ID: 15591498
[TBL] [Abstract][Full Text] [Related]
12. Demographic, socio-economic and other associated risk factors for self-medication behaviour among university students of Sri Lanka: a cross sectional study.
Subashini N; Udayanga L
BMC Public Health; 2020 May; 20(1):613. PubMed ID: 32366238
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and associated features of gastroesophageal reflux symptoms in a Caucasian-predominant adolescent school population.
Gunasekaran TS; Dahlberg M; Ramesh P; Namachivayam G
Dig Dis Sci; 2008 Sep; 53(9):2373-9. PubMed ID: 18204971
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea.
Cho YS; Choi MG; Jeong JJ; Chung WC; Lee IS; Kim SW; Han SW; Choi KY; Chung IS
Am J Gastroenterol; 2005 Apr; 100(4):747-53. PubMed ID: 15784014
[TBL] [Abstract][Full Text] [Related]
15. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of reflux symptoms and GORD.
Ronkainen J; Agréus L
Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):325-37. PubMed ID: 23998972
[TBL] [Abstract][Full Text] [Related]
17. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
[TBL] [Abstract][Full Text] [Related]
18. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors of gastro-oesophageal reflux symptoms among adolescents, the HUNT study.
Visnes ES; Hallan A; Bomme M; Holmberg D; Møller-Hansen J; Lagergren J; Ness-Jensen E
Scand J Gastroenterol; 2024 Jul; 59(7):816-820. PubMed ID: 38756009
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
Monés J
Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
